Literature DB >> 3729357

Antibacterial activity of GO 10213, a nitroimidazole derivative.

H Hof, J Ströder.   

Abstract

Compound GO 10213, a 5-nitroimidazole substituted at the 2 position, is more active against aerobic, microaerophilic, and anaerobic bacteria than metronidazole. The MICs for Salmonella typhimurium (2 to 128 micrograms/ml), Campylobacter spp. (0.06 to 16 micrograms/ml) and Bacteroides spp. (0.03 to 0.25 micrograms/ml) are definitely lower than those of metronidazole. Niridazole, a 5-nitrothiazole, is still more active.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729357      PMCID: PMC284192          DOI: 10.1128/AAC.29.5.953

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Systemic treatment of human trichomoniasis with a derivative of nitro-imidazole, 8823 RP.

Authors:  P DUREL; V ROIRON; A SIBOULET; L J BOREL
Journal:  Br J Vener Dis       Date:  1960-03

2.  Anti-anaerobic antibacterial agents.

Authors:  J G Bartlett
Journal:  Lancet       Date:  1982-08-28       Impact factor: 79.321

3.  Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.

Authors:  V L Sutter; A L Barry; T D Wilkins; R J Zabransky
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

4.  Comparative efficacy of Go 10213 and some nitroimidazoles against Trichomonas vaginalis and T. Foetus in mice infected subcutaneously.

Authors:  D K Ray; D K Chatterjee; J S Tendulkar
Journal:  Ann Trop Med Parasitol       Date:  1982-04

Review 5.  The development of 5-nitroimidazoles for the treatment and prophylaxis of anaerobic bacterial infections.

Authors:  P Goldman
Journal:  J Antimicrob Chemother       Date:  1982-08       Impact factor: 5.790

6.  Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.

Authors:  H Hof; V Sticht-Groh; K M Müller
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

7.  Antibacterial activities of nitrothiazole derivatives.

Authors:  H Hof; O Zak; E Schweizer; A Denzler
Journal:  J Antimicrob Chemother       Date:  1984-07       Impact factor: 5.790

8.  Pre-clinical toxicity studies on the new nitroimidazole 1-methylsulphonyl-3-(1-methyl-5-nitroimidazole-2-yl)-2- imidazolidinone.

Authors:  R R Rao; T B Nair; M R Marathe; S D Gangoli
Journal:  Arzneimittelforschung       Date:  1985

9.  A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.

Authors:  D K Ray; J S Tendulkar; V B Shrivastava; A K Datta; K Nagarajan
Journal:  J Antimicrob Chemother       Date:  1984-10       Impact factor: 5.790

Review 10.  Mutagenicity and genotoxicity of nitroarenes. All nitro-containing chemicals were not created equal.

Authors:  H S Rosenkranz; R Mermelstein
Journal:  Mutat Res       Date:  1983-04       Impact factor: 2.433

  10 in total
  1 in total

Review 1.  Nitroimidazoles for the treatment of TB: past, present and future.

Authors:  Tathagata Mukherjee; Helena Boshoff
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.